Search for information about a product,
therapeutic area or event

Search

Media, investors, advocacy organizations and others, please contact us here.

Hero Section Background Image

Publications

Access Travere’s peer-reviewed publications.

Long-Term Outcomes in IgA Nephropathy
Publication NephrologyIgAN

Long-Term Outcomes in IgA Nephropathy

Clinical Journal of the American Society of Nephrology – 2023

Data from the UK National Registry of Rare Kidney Diseases (RaDaR) IgA nephropathy cohort highlight poor long-term outcomes for patients. Read more.

View summary
Long-Term Outcomes in Nephrotic Syndrome by Kidney Biopsy Diagnosis and Proteinuria
Publication NephrologyFSGS

Long-Term Outcomes in Nephrotic Syndrome by Kidney Biopsy Diagnosis and Proteinuria

Journal of the American Society of Nephrology – 2025

Data from the UK National Registry of Rare Kidney Diseases (RaDaR) nephrotic syndrome cohort demonstrated poor kidney outcomes. Read more.

View summary
The Humanistic Burden of Focal Segmental Glomerulosclerosis on Patients and Care‑Partners in the United States
Publication NephrologyFSGS

The Humanistic Burden of Focal Segmental Glomerulosclerosis on Patients and Care‑Partners in the United States

Quality of Life Research – 2025

Data from the Humanistic Burden of Rare KidNey Diseases: Understanding the impact of FSGS and IgAN on Patients and Caregivers Study (HONUS) showed that FSGS significantly impairs quality of life for both patients and care-partners. Read more.

View summary

All our publications

Filter by:

Year

Year

×
Clear All

Therapeutic area

Therapeutic area

×
Clear All

Disease area

Disease area

×
Clear All

Product

Product

×
Clear All

Study/Registry

Study/Registry

×
Clear All

Study type

Study type

×
Clear All

Resource type

Resource type

×
Clear All
Clear All

Filter by:

Year

Year

×
Clear All

Therapeutic area

Therapeutic area

×
Clear All

Disease area

Disease area

×
Clear All

Product

Product

×
Clear All

Study/Registry

Study/Registry

×
Clear All

Study type

Study type

×
Clear All

Resource type

Resource type

×
Clear All

Results50

Sort by

KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
Publication NephrologyIgAN

KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)

Kidney International – 2025

Not funded by Travere

Read more
Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis
Publication NephrologyFSGS

Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis

Kidney Medicine – 2022

Read more
Sparsentan Improves Glomerular Hemodynamics, Cell Functions, and Tissue Repair in a Mouse Model of FSGS
Publication NephrologyFSGS

Sparsentan Improves Glomerular Hemodynamics, Cell Functions, and Tissue Repair in a Mouse Model of FSGS

JCI Insight – 2024

Read more
Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry
Publication NephrologyIgAN

Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry

Kidney Medicine – 2025

Read more
The Humanistic Burden of Focal Segmental Glomerulosclerosis on Patients and Care‑Partners in the United States
Publication NephrologyFSGS

The Humanistic Burden of Focal Segmental Glomerulosclerosis on Patients and Care‑Partners in the United States

Quality of Life Research – 2025

Read more
Population Risk Predictors of Major Adverse Kidney Events Attributed to FSGS from the CURE-CKD Registry
Publication NephrologyFSGS

Population Risk Predictors of Major Adverse Kidney Events Attributed to FSGS from the CURE-CKD Registry

BMC Nephrology – 2025

Read more
Load more

The publications featured on this page have been partially or fully funded by Travere Therapeutics, Inc., unless noted otherwise. For more information, please refer to the publication.

MSL CTA Image

Connect with our MSL team today

Arrange a meeting with a member of our medical science liaison (MSL) team to discuss the latest insights, clinical trial data, and management trends.

Find your MSL